| 5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation M Fesatidou, P Zagaliotis, C Camoutsis, A Petrou, P Eleftheriou, C Tratrat, ... Bioorganic & Medicinal Chemistry 26 (16), 4664-4676, 2018 | 72 | 2018 |
| Novel antifungal agents in clinical trials SE Jacobs, P Zagaliotis, TJ Walsh F1000Research 10, 507, 2022 | 50 | 2022 |
| Thiazole/thiadiazole/benzothiazole based thiazolidin-4-one derivatives as potential inhibitors of main protease of SARS-CoV-2 A Petrou, P Zagaliotis, NF Theodoroula, GA Mystridis, IS Vizirianakis, ... Molecules 27 (7), 2180, 2022 | 28 | 2022 |
| Therapeutic bacteriophages for Gram-negative bacterial infections in animals and humans P Zagaliotis, J Michalik-Provasek, JJ Gill, TJ Walsh Pathogens and Immunity 7 (2), 1, 2022 | 24 | 2022 |
| Recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) as adjuvant therapy for invasive fungal diseases TK Chen, JS Batra, DE Michalik, J Casillas, R Patel, ME Ruiz, H Hara, ... Open Forum Infectious Diseases 9 (11), ofac535, 2022 | 20 | 2022 |
| Identification of novel cyclooxygenase-1 selective inhibitors of thiadiazole-based scaffold as potent anti-inflammatory agents with safety gastric and cytotoxic profile M Haroun, M Fesatidou, A Petrou, C Tratrat, P Zagaliotis, A Gavalas, ... Molecules 28 (8), 3416, 2023 | 7 | 2023 |
| Discovery of 5-methylthiazole-thiazolidinone conjugates as potential anti-inflammatory agents: molecular target identification and in silico studies M Haroun, A Petrou, C Tratrat, A Kolokotroni, M Fesatidou, P Zagaliotis, ... Molecules 27 (23), 8137, 2022 | 7 | 2022 |
| Developing new treatments for COVID-19 through dual-action antiviral/anti-inflammatory small molecules and physiologically based pharmacokinetic modeling P Zagaliotis, A Petrou, GA Mystridis, A Geronikaki, IS Vizirianakis, ... International Journal of Molecular Sciences 23 (14), 8006, 2022 | 5 | 2022 |
| Developing and characterizing bacteriophage for therapeutic use against carbapenem‐resistant Enterobacteriaceae in a multiple drug resistant Klebsiella pneumoniae model J Michalik-Provasek, L Lessor, E Mavridou, P Zagaliotis, T Walsh, J Gill The FASEB Journal 34 (S1), 1-1, 2020 | 2 | 2020 |
| Bacteriophage Treatment against Carbapenem-resistant Klebsiella pneumoniae (KPC) in a Neutropenic Murine Model of Gastrointestinal Translocation and Renal … P Zagaliotis, J Michalik-Provasek, E Mavridou, E Naing, IS Vizirianakis, ... bioRxiv, 2024.06. 21.600121, 2024 | 1 | 2024 |
| Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation … P Zagaliotis, J Michalik-Provasek, E Mavridou, E Naing, IS Vizirianakis, ... Antimicrobial Agents and Chemotherapy 69 (2), e00919-24, 2025 | | 2025 |
| Isolation, characterization and therapeutic application of bacteriophages in a murine model of gastrointestinal colonization and translocation of multidrug resistant Klebsiella … P Zagaliotis Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Σχολή Επιστημών Υγείας. Τμήμα …, 2023 | | 2023 |
| Novel antifungal agents in clinical trials [version 1; peer SE Jacobs, P Zagaliotis, TJ Walsh | | 2021 |
